Executive Decisions Roundup
This article was originally published in The Tan Sheet
Another Coca-Cola exec pops up at NBTY; Hussain helms Glaxo pharma globally; China TCM office veteran returns; T-Bird tabs Huang as COO; and Lee named Calif. DTSC director.
You may also be interested in...
Steven Cahillane, who left his post as president of Coca-Cola Co.’s Americas division in 2013, is moving to NBTY to replace Jeffrey Nagel after the supplement manufacturer and retailer reported flat sales for its most recent earnings period and after net income dropped nearly 12% during the firm’s previous fiscal year.
Tianeptine isn’t approved as drug in US nor allowed for use as dietary ingredient or food additive. FDA has warned multiple firms selling tianeptine-containing products and federal prosecutors recently announced guilty plea from man who sold the drug to consumers.
BBB National Programs’ NARB “troubled” because 50% more electrolytes claim is unclear which Gatorade product the claim references. It finds consumers will understand “leading sports drink” claim references Gatorade and “ambiguous reference” makes “incorrect message” Powerade has 50% more electrolytes than all Gatorade products rather than Gatorade Thirst Quencher alone.